2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC19
  



  

  

  



  

  
Submitter : 
  

  
Dr. David  Healy
  

  
Date & Time: 
  

  
09/03/2004 06:09:44
  



  

  
Organization : 
  

  
Cardiff University
  



  

  
Health Professional
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Recently, Pfizer have posted on the FDA website announcing the forthcoming PDAC hearings on September 13th an ad hominem attack on me. This was apparently cleared by Daniel Troy, chief counsel to the FDA before posting.  The attached documents constitute a preliminary response which I would hope to supplement at the hearings on the 13th.